AstraZeneca: HSBC Cuts Target Price To 16500p From 17200p
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.